190 related articles for article (PubMed ID: 29442342)
21. Long-term outcomes in patients with adult-onset craniopharyngioma.
Dogra P; Bedatsova L; Van Gompel JJ; Giannini C; Donegan DM; Erickson D
Endocrine; 2022 Oct; 78(1):123-134. PubMed ID: 35869972
[TBL] [Abstract][Full Text] [Related]
22. Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity.
Gallotti AL; Barzaghi LR; Albano L; Medone M; Gagliardi F; Losa M; Mortini P
Pituitary; 2022 Feb; 25(1):74-84. PubMed ID: 34236593
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.
Müller HL; Emser A; Faldum A; Bruhnken G; Etavard-Gorris N; Gebhardt U; Oeverink R; Kolb R; Sörensen N
J Clin Endocrinol Metab; 2004 Jul; 89(7):3298-305. PubMed ID: 15240606
[TBL] [Abstract][Full Text] [Related]
24. Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome.
Elliott RE; Sands SA; Strom RG; Wisoff JH
Neurosurg Focus; 2010 Apr; 28(4):E2. PubMed ID: 20367359
[TBL] [Abstract][Full Text] [Related]
25. Primary adult infradiaphragmatic craniopharyngiomas: clinical features, management, and outcomes in one Chinese institution.
Wang L; Ni M; Jia W; Jia G; Du J; Li G; Zhang J; Wang Z
World Neurosurg; 2014; 81(5-6):773-82. PubMed ID: 23396074
[TBL] [Abstract][Full Text] [Related]
26. Recovery from diabetes insipidus and preservation of thyroid function after craniopharyngioma removal and pituitary stalk sectioning.
Ogawa Y; Niizuma K; Tominaga T
Clin Neurol Neurosurg; 2017 Nov; 162():36-40. PubMed ID: 28917091
[TBL] [Abstract][Full Text] [Related]
27. Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children.
Shohdy KS; Rashad W
Pediatr Endocrinol Rev; 2017 Mar; 14(3):298-301. PubMed ID: 28508600
[TBL] [Abstract][Full Text] [Related]
28. Influence of tumor location on the presentation and evolution of craniopharyngiomas.
Meuric S; Brauner R; Trivin C; Souberbielle JC; Zerah M; Sainte-Rose C
J Neurosurg; 2005 Nov; 103(5 Suppl):421-6. PubMed ID: 16302613
[TBL] [Abstract][Full Text] [Related]
29. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Kendall-Taylor P; Jönsson PJ; Abs R; Erfurth EM; Koltowska-Häggström M; Price DA; Verhelst J
Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911
[TBL] [Abstract][Full Text] [Related]
30. Very long-term sequelae of craniopharyngioma.
Wijnen M; van den Heuvel-Eibrink MM; Janssen JAMJL; Catsman-Berrevoets CE; Michiels EMC; van Veelen-Vincent MC; Dallenga AHG; van den Berge JH; van Rij CM; van der Lely AJ; Neggers SJCMM
Eur J Endocrinol; 2017 Jun; 176(6):755-767. PubMed ID: 28325825
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas.
Mortini P; Gagliardi F; Bailo M; Spina A; Parlangeli A; Falini A; Losa M
Endocrine; 2016 Jan; 51(1):148-62. PubMed ID: 26179178
[TBL] [Abstract][Full Text] [Related]
32. The Role of Tumor-Associated Hypothalamic Involvement in Surgical Treatment and Long-Term Outcome in Adult Patients with Craniopharyngioma.
Lucia K; Gudehus A; Seifert V; Czabanka M; Jussen D
World Neurosurg; 2024 Feb; 182():e525-e535. PubMed ID: 38061542
[TBL] [Abstract][Full Text] [Related]
33. Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Müller HL
Pituitary; 2017 Apr; 20(2):267-281. PubMed ID: 27604996
[TBL] [Abstract][Full Text] [Related]
34. [Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].
Sterkenburg AS; Hoffmann A; Gebhardt U; Waldeck E; Springer S; Müller HL
Klin Padiatr; 2014 Nov; 226(6-7):344-50. PubMed ID: 25431867
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcome After Extended Endoscopic Endonasal Resection of Craniopharyngiomas: Two-Institution Experience.
Park HR; Kshettry VR; Farrell CJ; Lee JM; Kim YH; Won TB; Han DH; Do H; Nyguist G; Rosen M; Kim DG; Evans JJ; Paek SH
World Neurosurg; 2017 Jul; 103():465-474. PubMed ID: 28433845
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Guo Y; Pei L; Li Y; Li C; Gui S; Ni M; Liu P; Zhang Y; Zhong L
Front Endocrinol (Lausanne); 2023; 14():1180591. PubMed ID: 37324266
[TBL] [Abstract][Full Text] [Related]
37. Craniopharyngioma: long-term consequences of a chronic disease.
Müller HL
Expert Rev Neurother; 2015; 15(11):1241-4. PubMed ID: 26523617
[TBL] [Abstract][Full Text] [Related]
38. Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas.
Zoli M; Sambati L; Milanese L; Foschi M; Faustini-Fustini M; Marucci G; de Biase D; Tallini G; Cecere A; Mignani F; Sturiale C; Frank G; Pasquini E; Cortelli P; Mazzatenta D; Provini F
Neurosurg Focus; 2016 Dec; 41(6):E12. PubMed ID: 27903128
[TBL] [Abstract][Full Text] [Related]
39. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Roth CL; Eslamy H; Werny D; Elfers C; Shaffer ML; Pihoker C; Ojemann J; Dobyns WB
Obesity (Silver Spring); 2015 Jun; 23(6):1226-33. PubMed ID: 25884561
[TBL] [Abstract][Full Text] [Related]
40. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results.
Pollock BE; Lunsford LD; Kondziolka D; Levine G; Flickinger JC
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):437-46. PubMed ID: 7673031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
